JP2024532957A5 - - Google Patents
Info
- Publication number
- JP2024532957A5 JP2024532957A5 JP2024533929A JP2024533929A JP2024532957A5 JP 2024532957 A5 JP2024532957 A5 JP 2024532957A5 JP 2024533929 A JP2024533929 A JP 2024533929A JP 2024533929 A JP2024533929 A JP 2024533929A JP 2024532957 A5 JP2024532957 A5 JP 2024532957A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- liver
- fibrosis
- elf
- score
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163233133P | 2021-08-13 | 2021-08-13 | |
| US63/233,133 | 2021-08-13 | ||
| PCT/US2022/040227 WO2023018972A1 (en) | 2021-08-13 | 2022-08-12 | Methods and compositions for treating fibrotic liver conditions, using udenafil compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532957A JP2024532957A (ja) | 2024-09-10 |
| JP2024532957A5 true JP2024532957A5 (https=) | 2025-08-19 |
Family
ID=83355014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533929A Pending JP2024532957A (ja) | 2021-08-13 | 2022-08-12 | ウデナフィル組成物を用いた線維肝状態を処置する方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20230218622A1 (https=) |
| EP (1) | EP4384176A1 (https=) |
| JP (1) | JP2024532957A (https=) |
| AU (1) | AU2022325803A1 (https=) |
| CA (1) | CA3229274A1 (https=) |
| MX (1) | MX2024001972A (https=) |
| WO (1) | WO2023018972A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12396708B2 (en) * | 2024-01-08 | 2025-08-26 | Echosens Sa | Method for determining an index for assessing a cardiac function of a subject |
| EP4582017A1 (en) * | 2024-01-08 | 2025-07-09 | Echosens | Method for determining an index for assessing a cardiac function of a subject |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0202254D0 (en) * | 2002-01-31 | 2002-03-20 | Pfizer Ltd | Prevention of scarring |
| PT1888074E (pt) * | 2005-06-10 | 2012-03-01 | Dong A Pharm Co Ltd | Agente para a prevenção e tratamento de doenças do fígado contendo um derivado de pirazolopirimidina |
| TN2017000029A1 (en) | 2014-08-12 | 2018-07-04 | Mezzion Pharma Co Ltd | Methods of improving myocardial performance in fontan patients using udenafil compositions |
-
2022
- 2022-08-12 AU AU2022325803A patent/AU2022325803A1/en active Pending
- 2022-08-12 EP EP22772634.6A patent/EP4384176A1/en active Pending
- 2022-08-12 JP JP2024533929A patent/JP2024532957A/ja active Pending
- 2022-08-12 CA CA3229274A patent/CA3229274A1/en active Pending
- 2022-08-12 US US17/887,091 patent/US20230218622A1/en active Pending
- 2022-08-12 WO PCT/US2022/040227 patent/WO2023018972A1/en not_active Ceased
-
2024
- 2024-02-13 MX MX2024001972A patent/MX2024001972A/es unknown
-
2025
- 2025-01-18 US US19/031,865 patent/US20250186448A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024532957A5 (https=) | ||
| CN108882744B (zh) | 含有益智提取物的组合物以及益智提取物的用途 | |
| WO2008122190A1 (en) | The composition comprising l-carnitine or derivatives thereof and its use | |
| JP2001199882A (ja) | 感冒・鼻炎用組成物 | |
| AU2017327383A1 (en) | Method of reducing thyroid-associated side effects | |
| EP2988750B9 (en) | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias | |
| JP2022511788A5 (https=) | ||
| JP2025515491A5 (https=) | ||
| CN108619138B (zh) | 血管紧张素受体拮抗剂和脑啡肽酶抑制剂的复合物及其用途 | |
| CN110664790A (zh) | 一种2,6-二(2-(三氟甲基)苯亚甲基)环己酮在药物制备中的应用 | |
| WO2008057464A2 (en) | Compositions and methods for improving the bioavailability of liothyronine | |
| JP2005511655A (ja) | 勃起障害の治療のためのアルカノイルｌ−カルニチンの使用 | |
| WO2025026900A1 (en) | Compounds for the treatment or prevention of gout | |
| JP2022518527A (ja) | パーキンソン病の患者を治療する方法 | |
| JP7366108B2 (ja) | ロキソプロフェン又はその塩及びビタミンｂ１２類を含有する経口用医薬組成物 | |
| JP2025505187A5 (https=) | ||
| JPS60215635A (ja) | アザプロパゾンを含有する医薬品製剤 | |
| TW201601715A (zh) | 膀胱‧尿道協同失調改善劑 | |
| JP2024520788A5 (https=) | ||
| JP2001507006A (ja) | 糖尿病性血管機能不全の予防のための薬剤の製造へのｃｏｍｔ阻害剤の使用 | |
| JP4702054B2 (ja) | 増強剤 | |
| JP2024518804A5 (https=) | ||
| KR20180038003A (ko) | 수축력 저하 수반성 배뇨근 과활동 개선제 | |
| WO2022004867A1 (ja) | 排尿症状治療剤 | |
| US20230270724A1 (en) | PDE3 inhibitors for treating viral infections |